Live Breaking News & Updates on Institute Of Biological Product

Stay updated with breaking news from Institute of biological product. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Research Roundup: COVAX urges dose sharing, FDA authorizes new drug, and Sinopharm vaccine results


email.
Last week, UNICEF signed an agreement with Human Vaccine, a subsidiary of the Russian Direct Investment Fund, for supply of up to 220 million doses of the Sputnik V COVID-19 vaccine. Procurement of the doses will be contingent on the vaccine receiving emergency use listing from the World Health Organization (WHO) and an advance purchase agreement with Gavi, the Vaccine Alliance, for the COVAX vaccine-sharing facility. The organizations leading COVAX also made an announcement last week renewing the call for funding and vaccine sharing, urging countries to share at least 1 billion doses in 2021. COVAX has so far delivered more than 70 million doses to 126 countries and economies since February, but it will face a shortfall of 190 million doses by the end of June, according to the statement. ....

New York , United States , United Kingdom , South Africa , World Health Organization , Al Qahirah , Vaccine Alliance , Journal Of The American Medical Association , Russian Direct Investment Fund , Drug Administration On , Institute Of Biological Products , Institute Of Biological Product , Wuhan Institute Of Biological Products , Human Vaccine , Drug Administration , Vir Biotechnology , American Medical , Wuhan Institute , Biological Products , Beijing Institute , Biological Product , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , தடுப்பூசி கூட்டணி ,